LEP and breast cancer: Although inflammation is suggested to promote carcinogenesis and leptin is a pro-inflammatory cytokine, our results in premenopausal women are supported by experiments indicating that high levels of leptin might reduce breast cancer through regulation of ovarian folliculogenesis [37] and the reduction of follicular oestradiol secretion [38].